Sort   by:  
 Page size 
ProteomicsRobust and easy-to-use one pot workflow for label free single cell proteomics
The analysis of ultra-low input samples or even individual cells is essential to answering a multitude of biomedical questions, but current proteomic workflows are limited in their sensitivity and reproducibility. Here we report a comprehensive workflow that includes optimized strategies for all ste...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-01-26 | MSV000091156 | MassIVE
UnknownBisphosphonates in multicentric osteolysis, nodulosis and arthropathy (MONA) spectrum disorder - an alternative therapeutic approach.
Not available
S-EPMC5043187 | biostudies-literature
UnknownMitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease.
Not available
S-EPMC10316771 | biostudies-literature
ProteomicsMm_synaptosome_iTRAQ_CID
Mouse synaptosomal proteome, CID
ORGANISM(S): Mus Musculus 
2014-12-31 | PAe005215 | PeptideAtlas
ProteomicsMm_synaptosome_iTRAQ_HCD
Mouse synaptosomal proteome, HCD
ORGANISM(S): Mus Musculus 
2014-12-31 | PAe005210 | PeptideAtlas
Genomicsena-DATASET-MUG-26-02-2014-10:25:52:632-26 - samples
In this study we performed whole genome sequencing of plasma DNA (plasma-Seq) of 19 plasma-DNA samples from a total of 10 patients treated with anti-EGFR therapy. We demonstrated that development of resistance to anti-EGFR therapies is frequently associated with focal amplifications of KRAS, MET, an...
EGAD00001000748 | EGA
Genomicsena-DATASET-MUG-29-10-2013-10:52:10:827-14 - samples
In this study we performed ultra deep sequencing of genes associated with anti-EGFR resistance, such as KRAS, BRAF, PIK3CA, and EGFR in 17 plasma-DNA samples from a total of 10 patients treated with anti-EGFR therapy.
EGAD00001000688 | EGA
GenomicsResistance to anti-EGFR therapy in colorectal cancer
Monoclonal antibodies targeting the Epidermal Growth Factor Receptor (EGFR), such as cetuximab and panitumumab, have evolved to important therapeutic options in metastatic colorectal cancer (CRC). However, almost all patients with clinical response to anti-EGFR therapies show disease progression wit...
EGAS00001000582 | EGA
ProteomicsH.sapiens - Cell line, Hela, SC (Kocher,proteomics,2014)
abundance based on Spectral counting, hela, Interaction consistency score: 22.0, Coverage: 20
ORGANISM(S): 9606 
2014-00-00 | 1305695320 | PAXDB
UnknownAzacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Not available
S-EPMC5343949 | biostudies-literature
Sort   by:  
 Page size